The rapid development of precision medicine has led to major innovations in histopathology. The synergy between increasingly sophisticated specialized services and the evolution of digital imaging techniques is opening up opportunities for new complementary diagnostics.
As a recognized player in histology for many years, Novaxia offers its customers the benefit of its expertise in the various R&D sectors: human health, veterinary, dermo-cosmetics.
We propose to support you throughout the pathology phase of your standard toxicology studies (in vivo safety) of pharmaceutical or agro-chemical products, implants or medical devices.
Our experts can also help you in the design of the pathology phase of specific non-GLP studies: safety/efficacy studies, pharmacology, disease models, etc.
Our portfolio ranges from complete tissue processing services, but also special materials such as hard tissues and medical devices, to the final analysis of the biomarkers of your choice. In addition, we offer a mobile necropsy service.